With the stock market on a tear, closing up five straight weeks in a row, many dividend bloggers have begun to echo the sentiment about finding relative bargains again.

In part 19 of my 54 part series on Dividend Aristocrats, I take a closer look at the future growth prospects and competitive advantage of medical products company CR Bard.

As a dividend growth investor I am always on the lookout for new investing opportunities.

Top scoring weekly returns: Buy and Hold 1 Year

September E-mini S&Ps (ESU14 +0.04%) this morning are up +0.01% and European stocks are up +0.22% as the markets await the latest monetary policy decision from the FOMC.

Everything you need to know about the markets in one post covering PG, NOC, YUM, BA, WRB, ILMN, IGT, DFS, BCR, SKX, FTI, CVA, JNPR, AMGN, GILD, CREE, VMW, T, ETN, APD, PX, R, TMO, DOW, BIIB, DAL, GCI, GD, TEL, JCI, APH, RAI, EMC, IR, NSC, AVY, LRCX, TSCO, CCI, FLS, EFX, ETFC, VAR, FB, XLNX, AVB, AIZ, TXT.